ArticleJournal of ovarian research2015
Novel reversible selective inhibitor of CRM1 for targeted therapy in ovarian cancer.
Xuejiao Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it
ArticleJournal of ovarian research2015
Xuejiao Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.